Finance

Lists
Why is BMKDF down 5,38%?
Dive Deeper
BMKDF:OTCMKTS
BioMark Diagnostics Inc
0,39 US$
-5,38%
(-0,022) 1D
30 სექ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BMKDF...
Open
0,39 US$
High
0,39 US$
Low
0,39 US$
Mkt. cap
57,50 მლნ.
Avg. vol.
1,65 ათ.
Volume
1,00 ათ.
52-wk high
0,50 US$
52-wk low
0,21 US$
Beta
0,01
Shares outstanding
106,48 მლნ.
Open
0,39 US$
High
0,39 US$
Low
0,39 US$
Mkt. cap
57,50 მლნ.
Avg. vol.
1,65 ათ.
Volume
1,00 ათ.
52-wk high
0,50 US$
52-wk low
0,21 US$
Beta
0,01
Shares outstanding
106,48 მლნ.
News stories
From web sources and news partners
The Dark Side Of The Boom
The Dark Side Of The Boom
·
42 წუთის წინ
BTIG’s Krinsky Says the Million-Dollar Question Is Turning Into a Major Frustration
marketscreener.com
marketscreener.com
·
30 წუთის წინ
S&P 500 index retreated after the Stockholm exchange closed on Wednesday
The Arkansas Democrat-Gazette
The Arkansas Democrat-Gazette
·
1 საათის წინ
Little Rock-based BSR files to list shares on New York Stock Exchange
WSJ
WSJ
·
6 საათის წინ
A Tech-Fueled Stock Market Powers Through, but Limps Into the Fourth Quarter
About BioMark Diagnostics Inc
CEO-
Employees-
Founded2014
HeadquartersRichmond, ბრიტანეთის კოლუმბია, კანადა
Sector-
Websitebiomarkdiagnostics.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
6,87 ათ.
6,92 ათ.
7,01 ათ.
7,01 ათ.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
190,09 ათ.
168,62 ათ.
196,56 ათ.
160,96 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
191,40 ათ.
191,88 ათ.
59,42 ათ.
160,10 ათ.
Operating expense
481,76 ათ.
526,42 ათ.
359,54 ათ.
421,17 ათ.
Total operating expenses
481,76 ათ.
526,42 ათ.
359,54 ათ.
421,17 ათ.
Operating income
-474,89 ათ.
-519,50 ათ.
-352,53 ათ.
-414,16 ათ.
Other non operating income
19,68 ათ.
163,16 ათ.
150,93 ათ.
54,55 ათ.
EBT including unusual items
-481,39 ათ.
-380,32 ათ.
-199,47 ათ.
-364,31 ათ.
EBT excluding unusual items
-481,39 ათ.
-380,32 ათ.
-199,47 ათ.
-364,31 ათ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-481,39 ათ.
-380,32 ათ.
-199,47 ათ.
-364,31 ათ.
Net profit margin
-7 006,16%
-5 499,16%
-2 846,32%
-5 198,43%
Earnings per share
-
-
-
-
Interest and investment income
18,38 ათ.
16,22 ათ.
15,24 ათ.
5,48 ათ.
Interest expense
-6,39 ათ.
-22,71 ათ.
-25,01 ათ.
-23,29 ათ.
Net interest expenses
12,00 ათ.
-6,49 ათ.
-9,76 ათ.
-17,81 ათ.
Depreciation and amortization charges
86,50 ათ.
141,02 ათ.
54,31 ათ.
100,11 ათ.
EBITDA
-470,84 ათ.
-515,36 ათ.
-348,39 ათ.
-409,90 ათ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები